ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $25 | $14 | $33 | $48 |
| - Cash | $13 | $13 | $8 | $21 |
| + Debt | $0 | $0 | $0 | $5 |
| Enterprise Value | $11 | $2 | $25 | $32 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$10 | $0 | -$6 |
| % Margin | – | – | – | -71,796.9% |
| EBITDA | $3 | -$18 | -$18 | -$9 |
| % Margin | – | – | – | -114,612.9% |
| Net Income | $3 | -$18 | -$18 | -$10 |
| % Margin | – | – | – | -118,662.2% |
| EPS Diluted | 2.75 | -35.5 | -42.5 | -41.75 |
| % Growth | 107.7% | 16.5% | -1.8% | – |
| Operating Cash Flow | -$27 | -$11 | -$17 | -$9 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$27 | -$11 | -$17 | -$9 |